METASTATIC KIDNEY CARCINOMA
Clinical trials for METASTATIC KIDNEY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC KIDNEY CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC KIDNEY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for kidney cancer patients
Disease control OngoingThis early-phase study looks at how safe and effective immunotherapy drugs (nivolumab alone or with bevacizumab or ipilimumab) are when given before surgery to people with kidney cancer that has spread. About 104 participants will receive these treatments to see how the body reac…
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New combo therapy aims to zap spine tumors before they paralyze
Disease control OngoingThis study tests whether using heat (thermal ablation) followed by very precise radiation (stereotactic radiosurgery) can better control cancer that has spread to the spine and is pressing on the spinal cord. About 60 adults with various solid tumors (like lung, breast, or prosta…
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New drug cocktail shows promise against tough kidney cancer
Disease control OngoingThis study tests a combination of two drugs—entinostat and aldesleukin—for people with kidney cancer that has spread. The goal is to find the safest dose and see if the combo can shrink tumors. About 47 adults with clear cell kidney cancer are taking part.
Matched conditions: METASTATIC KIDNEY CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC